Medical Devices

Prism Medical Reports CEO Medical Leave of Absence

TORONTO, ONTARIO: ...

New Data Presented at UEG Week Shows Use of WATS3D Significantly Increases Detection of Esophageal Pre-Cancer

BARCELONA, SPAIN: Compared to Standard Forceps Biopsy Alone, WATS3D Enhanced the Detection Rate of Barrett's Esophagus by 83.0% and Dysplasia by 88.5% in Multi-Center Community-Based Study ...

Ventripoint Corporate Update

SEATTLE, WASHINGTON: ...

Avita Medical Announces First Patient Treated in US Military Wound Trial

NORTHRIDGE, CA and CAMBRIDGE, UK: New Study at Walter Reed National Military Medical Center, Funded by US Department of Defense ...

Ventripoint Corporate Update

SEATTLE, WASHINGTON: ...

Body of Evidence Supporting the Use of Toraymyxin(TM) for Treatment of Septic Shock Continues to Grow

TORONTO, ONTARIO: ...

Avita Medical Provides Update on ReCell(R) Success in Treating Burn Victims in Taiwan

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: ...

Avita Medical to Present at 2015 Stem Cell Meeting on the Mesa

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: ...

B. Braun CEO to Share Insight and Perspective About Issues Facing MedTech Industry

BETHLEHEM, PA: Company Platinum Sponsor at AdvaMed 2015 MedTech Conference ...

Avita Medical Awarded US Government Contract Valued at up to $53.9m USD

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: Avita's ReCell(R) Device Receives Support for FDA Approval and to Be Procured by US Biomedical Advanced Research and Development Authority (BARDA) Under Federal Preparedness Plan for Mass Casualt ...